谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation.

Gulsum E. Pamuk,Edwin C. Y. Chow,Alexei C. Ionan,Haiyan Chen,Shwu-Luan Lee,Vicky Hsu,Manuela Grimstein,Nan Zheng,Jielin Sun,Rosane Charlab,Brenda J. Gehrke,Jonathon Vallejo,Lori A. Ehrlich,R. Angelo de Claro,Marc R. Theoret

Clinical Cancer Research（2024）

引用 0|浏览5
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要